Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coronavirus Disease 2019 (COVID-19) Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

NCT05020145 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05020145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05020145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coronavirus Disease 2019 (COVID-19) Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
August 25, 2021
Completion date
December 17, 2021
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breakthrough infection, covid-19, immunocompromised, immunosuppressed, sars-cov-2, sars-cov-2 infection